| A randomised, double-masked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal … R Narayanan, B Panchal, T Das, J Chhablani, S Jalali, MH Ali British Journal of Ophthalmology 99 (7), 954-959, 2015 | 127 | 2015 |
| Endophthalmitis: then and now N Relhan, RK Forster, HW Flynn Jr American journal of ophthalmology 187, xx-xxvii, 2018 | 122 | 2018 |
| Suicides in Northern India: comparison of trends and review of literature BR Sharma, M Gupta, AK Sharma, S Sharma, N Gupta, N Relhan, ... Journal of Forensic and Legal Medicine 14 (6), 318-326, 2007 | 90 | 2007 |
| Rose bengal photodynamic antimicrobial therapy: a novel treatment for resistant fusarium keratitis G Amescua, A Arboleda, N Nikpoor, H Durkee, N Relhan, MC Aguilar, ... Cornea 36 (9), 1141-1144, 2017 | 82 | 2017 |
| Pharmacokinetics of intravitreal antibiotics in endophthalmitis M Radhika, K Mithal, A Bawdekar, V Dave, A Jindal, N Relhan, T Albini, ... Journal of ophthalmic inflammation and infection 4, 1-9, 2014 | 82 | 2014 |
| Rose bengal photodynamic antimicrobial therapy for patients with progressive infectious keratitis: a pilot clinical study A Naranjo, A Arboleda, JD Martinez, H Durkee, MC Aguilar, N Relhan, ... American journal of ophthalmology 208, 387-396, 2019 | 76 | 2019 |
| Intracameral antibiotics and cataract surgery: endophthalmitis rates, costs, and stewardship SG Schwartz, HW Flynn, A Grzybowski, N Relhan, FL Ferris Ophthalmology 123 (7), 1411-1413, 2016 | 73 | 2016 |
| Endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility: literature review and options for treatment N Relhan, TA Albini, A Pathengay, AE Kuriyan, D Miller, HW Flynn British Journal of Ophthalmology 100 (4), 446-452, 2016 | 73 | 2016 |
| The Early Treatment Diabetic Retinopathy Study historical review and relevance to today's management of diabetic macular edema N Relhan, HW Flynn Jr Current opinion in ophthalmology 28 (3), 205-212, 2017 | 71 | 2017 |
| High-hyperopia database, part I: clinical characterisation including morphometric (biometric) differentiation of posterior microphthalmos from nanophthalmos N Relhan, S Jalali, N Pehre, HL Rao, U Manusani, L Bodduluri Eye 30 (1), 120-126, 2016 | 64 | 2016 |
| Endogenous endophthalmitis ET Cunningham, HW Flynn, N Relhan, M Zierhut Ocular immunology and inflammation 26 (4), 491-495, 2018 | 58 | 2018 |
| Endophthalmitis after clear corneal cataract surgery: outcomes over two decades NA Yannuzzi, N Si, N Relhan, AE Kuriyan, TA Albini, AM Berrocal, ... American journal of ophthalmology 174, 155-159, 2017 | 58 | 2017 |
| Endophthalmitis prophylaxis in cataract surgery: overview of current practice patterns around the world A Grzybowski, S G Schwartz, K Matsuura, S O Tone, S Arshinoff, J Q Ng, ... Current pharmaceutical design 23 (4), 565-573, 2017 | 51 | 2017 |
| Vancomycin-resistant Gram-positive bacterial endophthalmitis: epidemiology, treatment options, and outcomes M Khera, A Pathengay, A Jindal, S Jalali, A Mathai, RR Pappuru, ... Journal of ophthalmic inflammation and infection 3, 1-4, 2013 | 45 | 2013 |
| Misuse of prenatal diagnostic technology for sex-selected abortions and its consequences in India BR Sharma, N Gupta, N Relhan Public health 121 (11), 854-860, 2007 | 43 | 2007 |
| Endophthalmitis caused by nontuberculous mycobacterium: clinical features, antimicrobial susceptibilities, and treatment outcomes M Shah, N Relhan, AE Kuriyan, JL Davis, TA Albini, A Pathengay, D Miller, ... American journal of ophthalmology 168, 150-156, 2016 | 40 | 2016 |
| New therapeutic approaches in diabetic retinopathy K Vaziri, SG Schwartz, N Relhan, KS Kishor, HW Flynn Jr The review of diabetic studies: RDS 12 (1-2), 196, 2015 | 40 | 2015 |
| Clinical outcomes of 4-point scleral fixated 1-piece hydrophobic acrylic equiconvex intraocular lens using polytetrafluoroethylene suture NA Patel, P Shah, NA Yannuzzi, Z Ansari, JS Zaveri, N Relhan, ... Clinical Ophthalmology, 2145-2148, 2018 | 38 | 2018 |
| Rose bengal photodynamic antimicrobial therapy to inhibit Pseudomonas aeruginosa keratitis isolates H Durkee, A Arboleda, MC Aguilar, JD Martinez, KA Alawa, N Relhan, ... Lasers in medical science 35, 861-866, 2020 | 35 | 2020 |
| The role of systemic antimicrobials in the treatment of endophthalmitis: a review and an international perspective A Grzybowski, M Turczynowska, SG Schwartz, N Relhan, HW Flynn Ophthalmology and therapy 9, 485-498, 2020 | 34 | 2020 |
